Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May;94(5):399-402.
doi: 10.1136/jnnp-2022-330473. Epub 2023 Jan 23.

A roadmap to ALS prevention: strategies and priorities

Affiliations

A roadmap to ALS prevention: strategies and priorities

Michael Benatar et al. J Neurol Neurosurg Psychiatry. 2023 May.
No abstract available

Keywords: ALS.

PubMed Disclaimer

Conflict of interest statement

Competing interests: MB reports grants from the National Institutes of Health (R01-NS105479) and the Muscular Dystrophy Association; as well as consulting fees from Alector, Annexon, Biogen, Denali, Novartis, Orphazyme, Sanofi and UniQure. The University of Miami has licensed intellectual property to Biogen to support design of the ATLAS study. SAG reports grants from National Institutes of Health, Centers for Disease Control and Prevention (CDC/ATSDR), and the ALS Association, as well as consulting fees from Structure Films. He is listed as inventor on patent held by University of Michigan for the treatment of ALS and reports the participation on a Data Safety Monitoring Board or Advisory Board for Watermark. KAS reports consulting fees from the ALS Association. ELF reports grants from the National Institutes of Health, Centers for Disease Control and Prevention (CDC/ATSDR), the Novo Nordisk Foundation, and the Juvenile Diabetes Research Foundation. She is named as inventor on a patent held by University of Michigan titled 'Methods For Treating Amyotrophic Lateral Sclerosis' for treating ALS using JAK/STAT inhibitors and reports multiple positions on Data Safety Monitoring Boards, Advisory Boards or or other boards, as well as multiple editorial positions. MW reports grants from the National Institutes of Health and the Centers for Disease Control and Prevention, as well as consulting fees from the Spaulding Rehabilitation. He additionally reports membership on a Data Safety Monitoring Board or Advisory Board for Biogen, a leadership role for the International Society for Environmental Epidemiology, and an editorial position with Springer. ET reports a position in the Pa Rare Disease Task Force. KDD reports the support of the preparation of this manuscript from the ALS Association and the ASTDR’s National ALS Registry. NMT reports the support of the preparation of this manuscript from the ALS Association and the ASTDR’s National ALS Registry. AA-C reports consultancies or advisory boards for Amylyx, Apellis, Biogen, Brainstorm, Cytokinetics, GenieUs, GSK, Lilly, Mitsubishi Tanabe Pharma, Novartis, OrionPharma, Quralis and Wave Pharmaceuticals.

References

    1. Johnston CA, Stanton BR, Turner MR, et al. . Amyotrophic lateral sclerosis in an urban setting: a population based study of inner City London. J Neurol 2006;253:1642–3. 10.1007/s00415-006-0195-y - DOI - PubMed
    1. Miller TM, Cudkowicz ME, Genge A, et al. . Trial of antisense oligonucleotide tofersen for SOD1 ALS. NEJM 2022. 10.1056/NEJMoa2204705 - DOI - PubMed
    1. Dorst J, Ludolph AC, Huebers A. Disease-Modifying and symptomatic treatment of amyotrophic lateral sclerosis. Ther Adv Neurol Disord 2018;11:1756285617734734. 10.1177/1756285617734734 - DOI - PMC - PubMed
    1. Benatar M, Wuu J, McHutchison C, et al. . Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases. Brain 2022;145:27–44. 10.1093/brain/awab404 - DOI - PMC - PubMed
    1. Benatar M, Wuu J. Presymptomatic studies in ALS: rationale, challenges, and approach. Neurology 2012;79:1732–9. 10.1212/WNL.0b013e31826e9b1d - DOI - PMC - PubMed

Publication types

MeSH terms